|   | X |   | QUARTERLY      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31,  2009. |
|--------|---|--------|------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |   |   | TRANSITION      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 FOR THE TRANSITION PERIOD FROM ________________ TO      ________________. |
|--------|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Delaware                   |   | 04-2869857             |
|----------------------------|--------|------------------------|
| State      of Organization |   | IRS      Employer I.D. |

| 9033      Red Branch Road, Columbia,      Maryland  21045-2105 |
|--------------------------------------------------------------------------|
| (Address      of principal executive offices)                            |

| (443)      367-5500                                            |
|----------------------------------------------------------------|
| (Registrant’s      telephone number, including areacode) |

----

|                           |                              |                                                                                                            |        PageNumber |
|--------------------------------|-----------------------------------|-----------------------------------------------------------------------------------------------------------------|------------------------|
|   PART      I.  |   FINANCIAL      INFORMATION |                                                                                                            |
|                           |                              |                                                                                                            |
|                           | Item      1.                      | Financial      Statements                                                                                       |                   |
|                           |                              |                                                                                                            |                   |
|                           |                              | Consolidated      Balance Sheets; December      31, 2009 (unaudited) and September 30, 2009                     |  3                |   |
|                           |                              |                                                                                                            |                   |
|                           |                              | Consolidated      Statements of Operations; Three      Months Ended December 31, 2009 and 2008 (unaudited)      |  5                |   |
|                           |                              |                                                                                                            |                   |
|                           |                              | Consolidated      Statements of Cash Flows; Three      Months Ended December 31, 2009 and 2008 (unaudited) |  6                |   |
|                           |                              |                                                                                                            |                   |
|                           |                              | Notes      to Consolidated Financial Statements (unaudited)                                                     |  7                |   |
|                           |                              |                                                                                                            |                   |
|                           | Item      2.                      | Management’s      Discussion and Analysis of Financial Condition and Results of      Operation       |  11               |   |
|                           |                              |                                                                                                            |                   |
|                           | Item      3.                      | Quantitative      and Qualitative Disclosures About Market Risk                                                 |  14               |         |
|                           |                              |                                                                                                            |                   |
|                           | Item      4.                      | Controls      and Procedures                                                                                    |  14               |   |
|                           |                              |                                                                                                            |
| PART      II.                  | OTHER      INFORMATION            |                                                                                                            |
|                           |                              |                                                                                                            |                   |
|                           | Item      2.                      | Unregistered      Sales of Equity Securities and Use Of Proceeds                                                |  15               |   |
|                           |                              |                                                                                                            |                   |
|                           | Item      4.                      | Submission      of Matters to a Vote of Security Holders                                                        |  15               |   |
|                           |                              |                                                                                                            |                   |
|                           | Item      5                       | Other      Information                                                                                          |  15               |                 |
|                           |                              |                                                                                                            |                   |
|                           | Item      6.                      | Exhibits                                                                                                        |  16               |   |
|                           |                              |                                                                                                            |                   |
|        SIGNATURES         |  17                          |                                                                                                            |
|                           |                              |
|        CERTIFICATIONS     |                              |

----

|                                                                                                                                                                                       |   | December      31,2009 (unaudited) |      |   | September      30,2009 |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|----------------------------------------|-----------|--------|------------------------|--------|
| ASSETS                                                                                                                                                                                     |   |                                   |      |   |                   |   |
|                                                                                                                                                                                       |   |                                   |      |   |                   |   |
| CURRENT      ASSETS:                                                                                                                                                                       |   |                                   |      |   |                   |   |
|                                                                                                                                                                                       |   |                                   |      |   |                   |   |
| Cash                                                                                                                                                                                       |   | $                                      | 79,302    |   |                   | $      | 156,314 |   |
| Accounts      receivable, less allowance for doubtful accounts of $63,333 and $69,973      at  December 31, 2009      and September 30, 2009, respectively                       |   |                                   | 547,608   |   |                   |   | 630,020 |   |
| Inventories,      net                                                                                                                                                                      |   |                                   | 1,730,751 |   |                   |   | 1,703,226 |   |
| Current      portion of note receivable                                                                                                                                                    |   |                                   | 210,000   |   |                   |   | 210,000 |   |
| Prepaid      expenses and other current assets                                                                                                                                             |   |                                   | 127,035   |   |                   |   | 120,464 |   |
|                                                                                                                                                                                       |   |                                   |      |   |                   |   |   |   |
|              Total      current assets                                                                                    |   |                                   | 2,694,696 |   |                   |   | 2,820,024 |   |
|                                                                                                                                                                                       |   |                                   |      |   |                   |   |   |   |
| PROPERTY AND EQUIPMENT;      net of accumulated depreciation and amortization of   $6,198,230 and      $6,143,356 at December 31, 2009 and September 30, 2009,      respectively |   |                                   | 568,627   |   |                   |   | 599,008 |   |
|                                                                                                                                                                                       |   |                                   |      |   |                   |   |   |   |
| OTHER      ASSETS:                                                                                                                                                                         |   |                                   |      |   |                   |   |   |   |
|                                                                                                                                                                                       |   |                                   |      |   |                   |   |   |   |
| Long      term portion of note receivable                                                                                                                                                  |   |                                   | 192,500   |   |                   |   | 245,000 |   |
| Other      assets                                                                                                                                                                          |   |                                   | 54,068    |   |                   |   | 54,300 |   |
|              Total      other assets                                                                                      |   |                                   | 246,568   |   |                   |   | 299,300 |   |
|                                                                                                                                                                                       |   |                                   |      |   |                   |   |   |   |
| Total      Assets                                                                                                                                                                          |   | $                                      | 3,509,891 |   |                   | $      | 3,718,332 |   |

----

|                                                                                                                                                                                                                 |   | December      31,2009(unaudited) |        |   | September      30,2009 |   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|----------------------------------|-------------|--------|------------------------|--------|
|  LIABILITIES      AND STOCKHOLDERS’ DEFICIT                                                                                                                                                               |   |                             |        |   |                   |   |
|                                                                                                                                                                                                                 |   |                             |        |   |                   |   |
| CURRENT      LIABILITIES:                                                                                                                                                                                            |   |                             |        |   |                   |   |
| Accounts      payable and accrued liabilities                                                                                                                                                                        |   | $                                | 870,226     |   |                   | $      | 969,135 |   |
| Revolving      line of credit                                                                                                                                                                                        |   |                             | 424,000     |   |                   |   | 400,000 |   |
| Deferred      revenue                                                                                                                                                                                                |   |                             | 33,829      |   |                   |   | 51,830 |   |
| Note      Payable – Itau Bank                                                                                                                                                                                  |   |                             | 4,514       |   |                   |   | 28,859 |   |
| Total      Current Liabilities                                                                                                                                                                                       |   |                             | 1,332,569   |   |                   |   | 1,449,824 |   |
|                                                                                                                                                                                                                 |   |                             |        |   |                   |   |   |   |
| LONG      TERM LIABILITIES:                                                                                                                                                                                          |   |                             |        |   |                   |   |   |   |
| Senior      subordinated secured convertible notes                                                                                                                                                                   |   |                             | 4,049,858   |   |                   |   | 4,049,858 |   |
|                 Total      Long Term Liabilities                                                                                     |   |                             | 4,049,858   |   |                   |   | 4,049,858 |   |
|         Total      liabilities                                                                                                                                               |   |                             | 5,382,427   |   |                   |   | 5,499,682 |   |
|                                                                                                                                                                                                                 |   |                             |        |   |                   |   |   |   |
|  STOCKHOLDERS’      DEFICIT                                                                                                                                                                               |   |                             |        |   |                   |   |   |   |
|                                                                                                                                                                                                                 |   |                             |        |   |                   |   |   |   |
| Preferred      stock, $0.01 par value - 1,000,000 shares authorized; none      issued                                                                                                                                |   |                             | --          |   |                   |   | -- |   |
| Common      stock, $.01 par value - 30,000,000 shares authorized; 15,550,281 and      15,345,281 issued  and      outstanding  as of December 31, 2009 and September 30, 2009,      respectively |   |                             | 155,502     |   |                   |   | 153,452 |   |
| Additional      paid-in capital                                                                                                                                                                                      |   |                             | 22,933,537  |   |                   |   | 22,919,932 |   |
| Accumulated      deficit                                                                                                                                                                                             |   |                             | (24,868,142 | )      |                   |   | (24,734,125 | ) |
| Accumulated      other comprehensive loss-currency translation loss                                                                                                                                                  |   |                             | (3,796      | )      |                   |   | (30,972 | ) |
|  Less      treasury stock at cost; 100,000 shares at December 31,      2009  and September 30, 2009,    respectively.                                                                                 |   |                             | (89,637     | )      |                   |   | (89,637 | ) |
|           Total Stockholders’ Deficit                                                                                                                                                      |   |                             | (1,872,536  | )      |                   |   | (1,781,350 | ) |
| Total      Liabilities and Stockholders’ Deficit                                                                                                                                                               |   | $                                | 3,509,891   |   |                   | $      | 3,718,332 |   |
|                                                                                                                                                                                                                 |   |                             |        |   |                   |   |   |   |

----

|                                                                                                                                                                        |   | Three Months Ended    |       |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------------|------------|
|                                                                                                                                                                        |   | December      31,2009 |       |   | December      31,2008 |   |
| Net      Sales                                                                                                                                                              |   | $                     | 1,151,793  |   |   | $ | 1,386,350 |   |
| Cost      of Sales                                                                                                                                                          |   |                  | 642,669    |   |   |   | 877,646 |   |
| Gross      Profit                                                                                                                                                           |   |                  | 509,124    |   |   |   | 508,704 |   |
| Operating      Expenses:                                                                                                                                                    |   |                  |       |   |   |   |   |   |
|   Selling, general      and administrative                                                                                                                        |   |                  | 531,222    |   |   |   | 621,221 |   |
|   Research and      development                                                                                                                                   |   |                  | 16,880     |   |   |   | 22,957 |   |
|     Total      operating expenses                                                                                                                       |   |                  | 548,102    |   |   |   | 644,178 |   |
|     Total      operating loss                                                                                                                           |   |                  | (38,978    | ) |   |   | (135,474 | ) |
| Other      income (expenses):                                                                                                                                               |   |                  |       |   |   |   |   |   |
|   Interest expense      (net), includes $19,203 for the three months ended December      31, 2008     of debt      discount amortization |   |                  | (84,678    | ) |   |   | (99,846 | ) |
|   Other      expenses                                                                                                                                             |   |                  | (85        | ) |   |   | (49 | ) |
|   Gain on sale of      assets                                                                                                                                     |   |                  | --         |   |   |   | 43,117 |   |
|     Total      other expense                                                                                                                            |   |                  | (84,763    | ) |   |   | (56,778 | ) |
|                                                                                                                                                                        |   |                  |       |   |   |   |   |   |
|   Net loss before      income taxes                                                                                                                               |   |                  | (123,741   | ) |   |   | (192,252 | ) |
|                                                                                                                                                                        |   |                  |       |   |   |   |   |   |
|   Income Tax      expense                                                                                                                                         |   |                  | 10,276     |   |   |   | 16,248 |   |
|                                                                                                                                                                        |   |                  |       |   |   |   |   |   |
| Net      loss:                                                                                                                                                              |   |                  | (134,017   | ) |   |   | (208,500 | ) |
| Other      comprehensive income (loss), net of tax:                                                                                                                         |   |                  |       |   |   |   |   |   |
| Foreign      currency translation adjustments                                                                                                                               |   |                  | 27,176     |   |   |   | (186,594 | ) |
| Comprehensive      loss:                                                                                                                                                    |   | $                     | (106,841   | ) |   | $ | (395,094 | ) |
|                                                                                                                                                                        |   |                  |       |   |   |   |   |   |
| Loss      per share - Basic                                                                                                                                                 |   | $                     | (0.01      | ) |   | $ | (0.01 | ) |
| Loss      per share - Diluted                                                                                                                                               |   | $                     | (0.01      | ) |   | $ | (0.01 | ) |
| Weighted      average common shares used in calculation of earnings (loss) per share -      Basic                                                                           |   |                  | 15,436,966 |   |   |   | 15,225,281 |   |
| Weighted      average common shares used in calculation of earnings (loss) per share –      Diluted                                                                   |   |                  | 15,436,966 |   |   |   | 15,225,281 |   |

----

|                                                                                                                                                 |   | Three      Months EndedDecember      31, |     |
|------------------------------------------------------------------------------------------------------------------------------------------------------|--------|------------------------------------------|----------|
| Cash      flows from operating activities:                                                                                                           |   | 2009                                     |     |   | 2008 |   |
| Net      loss                                                                                                                                        |   | $                                        | (134,017 | ) |   | $ | (208,500 | ) |
| Adjustments      to reconcile net loss to net cash      provided by operating activities:                                                            |   |                                     |     |   |   |   |   |   |
|   Depreciation                                                                                                                             |   |                                     | 43,265   |   |   |   | 37,038 |   |
|   Amortization of      debt discount                                                                                                       |   |                                     | --       |   |   |   | 19,203 |   |
|   (Gain) on sale of      assets                                                                                                            |   |                                     | --       |   |   |   | (43,118 | ) |
|   Provision for Bad      Debts                                                                                                             |   |                                     | (7,904   | ) |   |   | 21,340 |   |
|   Stock Based      Compensation                                                                                                            |   |                                     | 15,655   |   |   |   | 2,731 |   |
| Changes      in operating assets and liabilities:                                                                                                    |   |                                     |     |   |   |   |   |   |
|   Accounts      receivable                                                                                                                 |   |                                     | 90,316   |   |   |   | 91,158 |   |
|   Prepaid expenses      and other current assets                                                                                           |   |                                     | (6,571   | ) |   |   | 164,111 |   |
|   Inventories                                                                                                                              |   |                                     | (27,525  | ) |   |   | 163,380 |   |
|   Accounts payable      and accrued expenses                                                                                               |   |                                     | (98,908  | ) |   |   | (169,805 | ) |
|   Other      assets                                                                                                                        |   |                                     | 231      |   |   |   | 34,703 |   |
|   Deferred      revenue                                                                                                                    |   |                                     | (18,001  | ) |   |   | 21,489 |   |
|     Net      cash (used in) provided by operating activities                                                                     |   |                                     | (143,459 | ) |   |   | 133,730 |   |
|                                                                                                                                                 |   |                                     |     |   |   |   |   |   |
| Cash      flows from investing activities:                                                                                                           |   |                                     |     |   |   |   |   |   |
| Purchase      of property and equipment                                                                                                              |   |                                     | (2,730   | ) |   |   | (95,259 | ) |
| Proceeds      from sale of assets                                                                                                                    |   |                                     | --       |   |   |   | 51,805 |   |
| Payments      Received on Notes Receivable                                                                                                           |   |                                     | 52,500   |   |   |   | 52,500 |   |
|     Net      cash provided by (used in) investing activities                                                                     |   |                                     | 49,770   |   |   |   | 9,046 |   |
|                                                                                                                                                 |   |                                     |     |   |   |   |   |   |
| Cash      flows from financing activities:                                                                                                           |   |                                     |     |   |   |   |   |   |
| Net      borrowings on Line of Credit                                                                                                                |   |                                     | 24,000   |   |   |   | -- |   |
| Payments      on Notes – Itau Bank                                                                                                             |   |                                     | (24,345  | ) |   |   | (55,568 | ) |
|     Net      cash used in financing activities                                                                              |   |                                     | (345     | ) |   |   | (55,568 | ) |
|                                                                                                                                                 |   |                                     |     |   |   |   |   |   |
| Effects      of foreign exchange rate                                                                                                                |   |                                     | 17,022   |   |   |   | (38,241 | ) |
|                                                                                                                                                 |   |                                     |     |   |   |   |   |   |
|                 Net (decrease)      increase in cash and cash equivalents |   |                                     | (77,012  | ) |   |   | 48,967 |   |
|                                                                                                                                                 |   |                                     |     |   |   |   |   |   |
| Cash      and cash equivalents at beginning of period                                                                                                |   |                                     | 156,314  |   |   |   | 98,799 |   |
|                                                                                                                                                 |   |                                     |     |   |   |   |   |   |
| Cash      and cash equivalents at end of period                                                                                                      |   | $                                        | 79,302   |   |   | $ | 147,766 |   |
| Supplemental      disclosure of cash flow information:                                                                                               |   |                                     |     |   |   |   |   |   |
|                                                                                                                                                 |   |                                     |     |   |   |   |   |   |
| Cash      paid during the period for interest                                                                                                        |   | $                                        | 60,562   |   |   | $ | 95,164 |   |

----

----

|                                                                                            |   | Three      Months EndedDecember      31, |       |
|-------------------------------------------------------------------------------------------------|--------|------------------------------------------|------------|
|                                                                                            |   | 2009                                     |       |   | 2008 |   |
|                                                                                            |   |                                     |       |   |   |   |
| Numerator:                                                                                      |   |                                     |       |   |   |   |
|         Net      loss                                   |   | $                                        | (137,017   | ) |   | $ | (208,500 | ) |
|                                                                                            |   |                                     |       |   |   |   |   |   |
| Denominator:                                                                                    |   |                                     |       |   |   |   |   |   |
|         Weighted      –average shares outstanding |   |                                     | 15,436,966 |   |   |   | 15,225,281 |   |
|         Effect      of dilutive shares                  |   |                                     | --         |   |   |   | -- |   |
|         Denominator      for diluted earnings per share |   |                                     | 15,436,966 |   |   |   | 15,225,281 |   |
|                                                                                            |   |                                     |       |   |   |   |   |   |
| Basic      Earnings per share                                                                   |   | $                                        | (0.01      | ) |   | $ | (0.01 | ) |
| Diluted      Earnings per share                                                                 |   | $                                        | (0.01      | ) |   | $ | (0.01 | ) |

|                                  |   | Three      Months EndedDecember      31, |       |
|---------------------------------------|--------|------------------------------------------|------------|
|                                  |   | 2009                                     |       |   | 2008 |   |
|                                  |   |                                     |       |   |   |   |
| Convertible      notes                |   |                                     | 11,571,000 |   |   |   | 5,399,800 |   |
| Options      to purchase common stock |   |                                     | 1,007,208  |   |   |   | 2,464,014 |   |
| Total      antidilutive instruments   |   |                                     | 12,578,208 |   |   |   | 7,863,814 |   |

----

|                                                                           |   |  Shares |      |   | Weighted      average exercise price |   |   | Weighted      averagelife |   |
|--------------------------------------------------------------------------------|--------|--------------|-----------|--------|--------------------------------------|--------|--------|---------------------------|--------|
|                                                                           |   |         |      |   |                                 |   |   |                      |   |
| Options      outstanding – October 1, 2009                               |   |         | 1,007,208 |   |                                 | $      | 0.23   |                      |   |   | 6.96 |   |
|        Granted                              |   |         | --        |   |                                 |   | --     |                      |   |   | -- |   |
|        Exercised                            |   |         | --        |   |                                 |   | --     |                      |   |   | -- |   |
|        Forfeited,      cancelled or expired |   |         | --        |   |                                 |   | --     |                      |   |   | -- |   |
| Options      outstanding – December 31, 2009                             |   |         | 1,007,208 |   |                                 | $      | 0.23   |                      |   |   | 6.96 |   |
| Options      exercisable – December 31, 2009                             |   |         | 917,208   |   |                                 | $      | 0.24   |                      |   |   | 7.33 |   |

|                  |   | December      31,2009 |      |   | September      30,2009 |   |
|-----------------------|--------|-----------------------|-----------|--------|------------------------|--------|
|                  |   |                  |      |   |                   |   |
| Raw      Materials    |   | $                     | 1,276,761 |   |                   | $      | 1,350,828 |   |
| Work-in-process       |   |                  | 115,622   |   |                   |   | 164,183 |   |
| Finished      goods   |   |                  | 1,065,222 |   |                   |   | 938,703 |   |
|                  |   |                  | 2,457,605 |   |                   |   | 2,453,714 |   |
| Less      reserves    |   |                  | (726,854  | )      |                   |   | (750,488 | ) |
| Inventories,      net |   | $                     | 1,730,751 |   |                   | $      | 1,703,226 |   |
|                  |   |                  |      |   |                   |   |   |   |

----

|                                                 |   | United*States |    |   | Brazil |   |    | Consolidated |   |
|------------------------------------------------------|--------|---------------|---------|--------|--------|--------|---------|--------------|--------|
| December      31, 2009:                              |   |          |    |   |   |   |    |         |   |
|      Revenues               |   |          | 526,483 |   |   |   | 625,310 |         |   |   | 1,151,793 |   |
|      Long-lived      assets |   |          | 392,718 |   |   |   | 422,477 |         |   |   | 815,195 |   |
|  December      31, 2008:                        |   |          |    |   |   |   |    |         |   |   |   |   |
|      Revenues               |   |          | 793,236 |   |   |   | 593,114 |         |   |   | 1,386,350 |   |
|      Long-lived      assets |   |          | 655,257 |   |   |   | 408,848 |         |   |   | 1,064,105 |   |

----

----

| · | Upgrading      the Analyst instrument and product offerings such as evaluating and      developing complimentary products for Hemagen’s Analyst product line to      distribute to the veterinarymarket; |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Developing      new ELISA kits and enhancing existing ELISA kits;  and |
|--------|------------------------------------------------------------------------|

| · | Developing      and enhancing IFA kits. |
|--------|-----------------------------------------|

----

----

----

| Period                   |        (a)Total      Number of Shares Purchased |  (b)AveragePrice      Paid per Share | (c) Total      Number of Shares Purchasedas      Part of Publicly Announced Plans      or Programs(1) | (d)Maximum      Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased      Under the Plans or Programs (2) |
|--------------------------|------------------------------------------------------------------------------------|-------------------------------------------|------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|
| October      1-31, 2009  | 6,500                                                                              | $0.09                                     | 6,500                                                                                                      | -                                                                                                                             |
| November      1-30, 2009 | -                                                                                  | -                                         | -                                                                                                          | -                                                                                                                             |
| December      1-31, 2009 | 2,620                                                                              | $0.09                                     | 2,620                                                                                                      | -                                                                                                                             |
| Total                    | 9,120                                                                              | $0.09                                     | 9,120                                                                                                      | -                                                                                                                             |

|   | (1) | Represents      shares of the Company’s Common Stock purchased pursuant to the Company’s      Employee Stock Ownership Plan (ESOP) that was established October 1, 2003      with no expiration.  The purpose of the plan is not to      repurchase, but rather it is an employee benefit  plan. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | There      is no maximum number of shares that may be purchased under the Company’s      Employee Stock Ownership Plan. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------|

----

| Exhibit      31.1 | Certification      of Principal Executive Officer pursuant to Rules 13a-14(a) and      15d-14(a)                                    |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------|
|              |                                                                                                                                |
| Exhibit      31.2 | Certification      of Principal Financial Officer pursuant to Rules 13a-14(a) and      15d-14(a)                                    |
|              |                                                                                                                                |
| Exhibit      32.1 | Certification      of Principal Executive Officer pursuant to Section 1350 of Chapter 63 of      Title 18 of the United States Code |
|              |                                                                                                                                |
| Exhibit      32.2 | Certification      of Principal Financial Officer pursuant to Section 1350 of Chapter 63 of      Title 18 of the United States Code |

----

|                   | Hemagen Diagnostics,      Inc.(Registrant) |                                            |
|------------------------|--------------------------------------------|-------------------------------------------------|
|                   |                                       |                                            |   |
| February 16,      2010 | By:                                        | /s/ William      P. Hales                  |   |
|                   |                                       | William      P. Hales                           |   |
|                   |                                       | President      and Chief      Executive Officer |   |
|                   |                                       | (Principal      /Executive Officer)             |   |

|                        |   |                                |   |
|------------------------|--------|-------------------------------------|--------|
| February 16,      2010 | By:    | /s/ Catherine      M. Davidson |   |
|                   |   | Catherine      M. Davidson          |   |
|                   |   | (Principal      Financial Officer)  |   |